News of Center PharmaCOVID |
|
I.S. Burashnikova
The rationale for re-administration of genetically engineered biological drugs in patients with COVID-19
|
11-14 |
|
I.S. Burashnikova
The rationale for the combined use of genetically engineered biological drugs in patients with COVID-19
|
15-19 |
|
|
S.E. Zhufina (1), K.A. Fomin (1), E.V. Svechnikova (1, 2)
Analysis of comorbid conditions and tolerability of treatment with genetically engineered biological drugs and methotrexate in patients with psoriasis
|
20-26 |
|
E.A. Orlova, Yu.A. Kandrashkina, E.M. Kostina
Neuroimmune interactions in the pathogenesis of atopic dermatitis: current state of the problem
|
27-33 |
|
N.A. Merzlikina (1), E.V. Svechnikova (1, 2), S.E. Zhufina (1)
Modern therapy of psoriasis from the point of view of systemic inflammation: experience of using the drug Efleira
|
34-41 |
|
I.V. Kosheleva (1, 3), O.A. Bitkina (2), L.I. Shadyzheva (1), O.V. Andriyakhina (3), A.Yu. Nikolaeva (2), M.N. Fyrnina (2), M.A. Deryavaya (2), K.S. Pershina (2), D.S. Zueva (2), A.A. Tsyganova (2)
On the dermatological aspects of the novel coronavirus infection (COVID-19)
|
42-47 |
|
Z.B. Marshani (1), E.V. Svechnikova (1, 2)
Experience with dupilumab in patients with atopic dermatitis
|
48-54 |
|
E.I. Yunusova, L.A. Yusupova, Z.Sh. Garaeva, G.I. Mavlyutova, O.P. Efremova
Erysipeloid of Rosenbach
|
55-58 |
|
N.A. Shanina, A.V. Patrushev, I. G. Kurganskaya, K.S. Grigoriev
Application of modern Q-Switched lasers for the correction of complex cosmetic facial skin defects
|
59-66 |
|
A.A. Grigorieva (1), L.V. Berzegova (1), K.V. Kozhina (1), E.V. Svechnikova (2)
Epi-Oral F199 – systemic anti-age therapy and antioxidant protection: ingredients
|
67-71 |
|
M.A. Beimanova (1), V.V. Petunina (2)
Promising directions for the development of photosensitizers for photodynamic therapy
|
72-76 |
|
K.A. Fomin (1, 2), N.A. Merzlikina (1), S.E. Zhufina (1), E.V. Svechnikova (1, 3)
Longitudinal systemic therapy of plaque psoriasis: a literature review with a case report of use of ixekizumab
|
77-86 |
ORIGINAL ARTICLES |
|
I.G. Kurganskaya, A.V. Patrushev, N.A. Shanina
Review of modern methods of prevention and correction of post-acne symptom complex
|
87-93 |
|
Yu.V. Maximova (1), D.M. Dultseva (1), V.E. Garny (1), E.O. Reshetnikova (1), V.N. Maximov (1, 2), E.V. Svechnikova (3)
Type 1 neurofibromatosis in Western Siberia, prevalence, features of clinical manifestations
|
94-98 |
|
N.O. Artemyeva (1), E.V. Svechnikova (1, 3), Yu.V. Maksimova (1), V.N. Maksimov (1, 2)
Urine chromatography in skin diseases
|
99-103 |
|
I.G. Afanasyeva, I.O. Malova
What is behind the mask of bacterial vaginosis?
|
104-111 |
|
M.A. Morzhanaeva (1), E.V. Shchepkina (2)
Analysis of anxiety-depressive states of patients with psoriasis and diabetes mellitus
|
112-116 |
|
A.S. Zhukov (1), E.R. Zharun (1), M.A. Chaykina (1), A.A. Chernyshova (2), V.R. Khairutdinov (1), A.V. Samtsov (1), A.V. Garabadzhiu (3)
Determination of the therapeutic efficacy of various concentrations of sivelestat on a laboratory model of psoriasis (Part 1)
|
117-122 |
|
A.S. Zhukov (1), E.R. Zharun (1), M.A. Chaykina (1), V.R. Khairutdinov (1), A.V. Samtsov (1), M.Yu. Krasavin (2), A.V. Garabadzhiu (3)
Evaluation of the safety and tolerability of a topical serine protease inhibitor (Part 2)
|
123-127 |
|
|
Z.Sh. Garayeva, L.A. Yusupova, E.I. Yunusova, G.I. Mavlyutova, Z.F. Yusupova
Annular granuloma
|
128-131 |
|
L.A. Yusupova, Z.Sh. Garaeva, E.I. Yunusova, G.I. Mavlyutova, I.I. Akhmetzyanova
Devergie’s disease
|
132-136 |
|
E.V. Svechnikova (1, 2)
Review of clinical trials of the IL-23 inhibitor guselkumab. Experience of using genetically engineered biological therapy with guselkumab in a patient with severe arthropathic psoriasis
|
137-146 |
|
K.V. Kozhina (1), A.A. Grigorieva (1), E.V. Svechnikova (2)
Injection bioreparation is a promising direction in the treatment of involutional skin changes
|
147-150 |
|
E.V. Svechnikova (1), L.V. Berzegova (2), K.V. Kozhina (2), A.A. Grigorieva (2)
A universal injectable preparation for the correction of cosmetological and dermatological skin problems
|
151-154 |
|
A.P. Brazhnikova, M.B. Paneiakh, I.A. Gorlanov, E.S. Manylova, E.S. Bolshakova
Sneddon-Wilkinson subcorneal pustulosis or IgA pemphigus?
|
156-161 |
|
Yu.A. Novikov (1), E.Yu. Zubareva (1), I.Yu. Lekavichus (2), A.S. Mitrofanova (3), E.K. Andreeva (1)
Clinical case of zoonotic trichophytosis in an adult woman: diagnostic error
|
162-165 |
|
O.B. Nemchaninova, E.Yu. Sklyanova, A.V. Sokolovskaya, E.V. Chernikova, T.B. Reshetnikova, O.N. Pozdnyakova
Clinical case of cutis verticis gyrata
|
166-170 |
|
L.V. Berzegova (1), K.V. Kozhina (1), A.A. Grigorieva (1), E.V. Svechnikova (2)
An innovative injection method for correcting excess adipose tissue in the face, submental area and neck
|
171-175 |
Русский
